ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients – Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?

BACKGROUND: ABO-incompatible (ABO-i) living donor liver transplantation (LDLT) is a feasible alternative for donor liver allograft in emergency situations, especially in Asia, where deceased-donor organs remain scarce. The reported outcomes of ABO-i LDLT after optimal desensitization are comparable...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Shih-Chao, Thorat, Ashok, Jeng, Long-Bin, Li, Ping-Chun, Yeh, Chun-Chieh, Chen, Te-Hung, Yang, Horng-Ren, Poon, Kin-Shing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526337/
https://www.ncbi.nlm.nih.gov/pubmed/32943600
http://dx.doi.org/10.12659/AOT.923502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526337/
https://www.ncbi.nlm.nih.gov/pubmed/32943600
http://dx.doi.org/10.12659/AOT.923502

Ejemplares similares